Publications
2022
Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease
Benedikt Simbrunner,
Ida Falk Villesen,
Philipp Königshofer,
Bernhard Scheiner,
David Bauer,
Rafael Paternostro,
Philipp Schwabl,
Gerald Timelthaler,
Dariga Ramazanova,
Katharina Wöran,
Judith Stift,
Ernst Eigenbauer,
Albert Friedrich Stättermayer,
Rodrig Marculescu,
Matthias Pinter,
Søren Møller,
Michael Trauner,
Morten Karsdal,
Diana Julie Leeming,
Thomas Reiberger,
Mattias Mandorfer.
Liver Int. 2022 Nov;42(11):2501-2512. doi: 10.1111/liv.15365. Epub 2022 Aug 25.
2022
Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertension
David Bauer,
Karin Kozbial,
Philipp Schwabl,
David Chromy,
Benedikt Simbrunner,
Albert F Stättermayer,
Matthias Pinter,
Petra Steindl-Munda,
Michael Trauner,
Peter Ferenci,
Thomas Reiberger,
Mattias Mandorfer.
Dig Liver Dis. 2022 Sep;54(9):1222-1229. doi: 10.1016/j.dld.2022.02.013. Epub 2022 Apr 3.
2022
Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension
Philipp Schwabl,
Berit Anna Seeland,
Florian Riedl,
Tim Lukas Schubert,
Philipp Königshofer,
Ksenia Brusilovskaya,
Oleksandr Petrenko,
Benedikt Hofer,
Ana-Iris Schiefer,
Michael Trauner,
Markus Peck-Radosavljevic,
Thomas Reiberger.
Adv Med Sci. 2022 Mar;67(1):154-162. doi: 10.1016/j.advms.2022.02.005. Epub 2022 Mar 8.
2021
Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failure.
Balcar L,
Semmler G,
Pomej K,
Simbrunner B,
Bauer D,
Hartl L,
Jachs M,
Paternostro R,
Bucsics T,
Pinter M,
Trauner M,
Mandorfer M,
Reiberger T,
Scheiner B.
United European Gastroenterol J. 2021 May;9(4):427-437. doi: 10.1002/ueg2.12089.
2021
Nuclear receptors in liver fibrosis.
Königshofer P,
Brusilovskaya K,
Petrenko O,
Hofer BS,
Schwabl P,
Trauner M,
Reiberger T.
Biochim Biophys Acta Mol Basis Dis. 2021 Dec 1;1867(12):166235. doi: 10.1016/j.bbadis.2021.166235. Epub 2021 Jul 31.
2021
Reply to: Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease"."
Simbrunner B,
Costa D,
Reiberger T.
J Hepatol. 2021 Apr 20:S0168-8278(21)00233-6. doi: 10.1016/j.jhep.2021.03.027. Online ahead of print.
2021
Reply to: Prognostic role of systemic inflammatory biomarkers in advanced chronic liver disease"."
Costa D,
Simbrunner B,
Reiberger T.
J Hepatol. 2021 Apr;74(4):1000-1001. doi: 10.1016/j.jhep.2021.01.026. Epub 2021 Jan 23.
2021
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality.
Costa D,
Simbrunner B,
Jachs M,
Hartl L,
Bauer D,
Paternostro R,
Schwabl P,
Scheiner B,
Stättermayer AF,
Pinter M,
Trauner M,
Mandorfer M,
Reiberger T.
J Hepatol. 2021 Apr;74(4):819-828. doi: 10.1016/j.jhep.2020.10.004. Epub 2020 Oct 16.
2021
The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model.
Schwabl P,
Hambruch E,
Budas GR,
Supper P,
Burnet M,
Liles JT,
Birkel M,
Brusilovskaya K,
Königshofer P,
Peck-Radosavljevic M,
Watkins WJ,
Trauner M,
Breckenridge DG,
Kremoser C,
Reiberger T.
Biomedicines. 2021 Jan 9;9(1):60. doi: 10.3390/biomedicines9010060.
2020
Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease.
Simbrunner B,
Marculescu R,
Scheiner B,
Schwabl P,
Bucsics T,
Stadlmann A,
Bauer DJM,
Paternostro R,
Eigenbauer E,
Pinter M,
Stättermayer AF,
Trauner M,
Mandorfer M,
Reiberger T.
Liver Int. 2020 Jul;40(7):1713-1724. doi: 10.1111/liv.14498. Epub 2020 May 18.
